Clinical Trials · NCT04663464

Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.

CompletedPhase 1Abaloparatide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Radius Health, Inc.
Enrollment
52
Start date
Nov 2020
Locations
1 site, United States
Primary endpoint
PK Cmax
View Abaloparatide compound reference